How to buy Ocugen stock
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
How do I buy Ocugen stock?
Shares of Ocugen can be purchased through any online brokerage account. There are several different types of brokers to choose from, and there are many online trading platforms, although each offers various features. Many online brokers are also discount brokers because they offer trades for $0. Such brokers may offer some level of assistance, but they mostly just execute trades for clients.
Popular online brokerages with access to the U.S. stock market include eToro, WeBull, TD Ameritrade, E*TRADE, Robinhood and more. Ocugen shares are listed on the NASDAQ under the ticker “OCGN.”
Should I buy Ocugen (OCGN) stock?
This year has been a bumpy ride for Ocugen (OCGN) investors, yet rewarding for those who were able to stomach the volatility. Ocugen’s success has been based on its seemingly improbable transformation from a company focused on eye diseases to one chasing the opportunities presented by Covid-19. It partnered with Bharat Biotech, the company developing the Indian version of the coronavirus vaccine called Covaxin. Lately investors have been cheering on the latest development in Ocugen’s attempt to bring the vaccine to market in the US.
Covaxin is a whole-virion inactivated COVID-19 vaccine based on a traditional approach. Unlike most current approved Covid-19 vaccines which use newer messenger RNA technologies or stem cell technologies, Covaxin should address concerns that have led to avoidance of the current vaccines.
Is it a good time to buy Ocugen (OCGN) stock?
According to data from Triangle Finance, the overall consensus is Moderate Buy with a consensus target of $7.90. Longer-term predictions suggested the share price could go up to $8 in one year and exceed $28 by 2027.
However, OCGN stock remains a remarkably risky investment for most investors at this time, especially for potential new investors. There are a lot of “ifs” surrounding Ocugen at this time. Hence, it’s tough to invest in OCGN stock at this time.
